HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea
· Delayed Price · Currency is KRW 27,150
-950 (-3.38%)
Feb 21, 2025, 3:30 PM KST
40.17% (1Y)
| Market Cap | 381.25B |
| Revenue (ttm) | 36.10B |
| Net Income (ttm) | 472.66M |
| Shares Out | 14.04M |
| EPS (ttm) | 34.13 |
| PE Ratio | 806.61 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 354,255 |
| Average Volume | 381,214 |
| Open | 28,100 |
| Previous Close | 28,100 |
| Day's Range | 26,850 - 28,500 |
| 52-Week Range | 15,150 - 42,050 |
| Beta | 0.41 |
| RSI | 57.14 |
| Earnings Date | n/a |